Plunkett Research Online: AEterna Zentaris Inc

AETERNA ZENTARIS INC (AEZS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license a.....

AEterna Zentaris Inc
Ticker: AEZS
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 843-900-3223
Address: 222 Bay Street
Suite 3000, PO Box 53
c/o Norton Rose Fulbright Canada, LLP
Toronto, ON M5K 1E7 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Development
Biopharmaceutical Development
Biopharmaceutical Licensing
Contacts Description
Klaus PauliniCEO/Director/Managing Director, Subsidiary/President
Giuliano La FrattaCFO/Senior VP
See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: